Related Experiment Video

Updated: Mar 24, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

9.0K

shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy

Jie Zhang1, Meng Ding1, Kai Xu1

  • 1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou, China.

Oncotarget
|March 17, 2016
PubMed

Insights

Conditionally replicating adenoviruses (CRAds) deliver short hairpin RNAs (shRNAs) to overcome limitations of small-interfering RNAs (siRNAs) in cancer therapy, showing promise for enhanced anti-tumor effects.

Area of Science:

  • Oncology
  • Gene Therapy
  • Viral Vectors

Background:

  • Small-interfering RNAs (siRNAs) show potential for cancer gene knockdown but face delivery challenges like short half-life and cytotoxicity.
  • Current siRNA delivery methods (synthetic duplexes, plasmids) exhibit limitations impacting therapeutic efficacy.

Purpose of the Study:

  • To review the progress of using conditionally replicating adenoviruses (CRAds) as vectors for short hairpin RNAs (shRNAs) in cancer treatment.
  • To highlight the potential of CRAds-shRNA to overcome existing siRNA delivery obstacles.

Main Methods:

  • Review of experimental studies and preclinical trials involving CRAds-shRNA.
  • Analysis of combination strategies for CRAds-shRNA with other cancer therapies.

Main Results:

  • CRAds-shRNA delivery overcomes limitations associated with synthetic siRNAs, demonstrating augmented anti-tumor effects.
  • CRAds-shRNA platforms show promise for efficient delivery of therapeutic RNAs and foreign genes.

Conclusions:

  • CRAds-shRNA represents a promising advancement in cancer gene therapy, addressing key delivery challenges.
  • Combination therapies involving CRAds-shRNA with chemotherapeutics, radiation, and immunotherapies are crucial for eradicating cancer and cancer stem cells.
Keywords:
RNA interferencecancerconditionally replicating adenovirusestarget therapy

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

7.6K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K